Aquestive Therapeutics Revenue
Pharmaceutical Manufacturing • 
Warren, New Jersey, United States • 101-200 Employees
Aquestive Therapeutics revenue & valuation
| Annual revenue | $44,200,000 |
| Revenue per employee | $301,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $141,300,000 |
| Total funding | $205,000,000 |
Key Contact at Aquestive Therapeutics
Company overview
| Headquarters | 30 Technology Drive, Warren, New Jersey 07059, US |
| Phone number | +19089411900 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 101-200 |
| Socials |
Aquestive Therapeutics Email Formats
Aquestive Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@aquestive.com), used 71.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@aquestive.com | 71.7% |
{first name}{last name} | johndoe@aquestive.com | 17.7% |
{last name}{last name} | doedoe@aquestive.com | 6.2% |
{first name} | john@aquestive.com | 1.8% |
About Aquestive Therapeutics
Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives. We are developing orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. Aquestive has five commercialized products on the U.S. market, four licensed products and one stand-alone proprietary product to date, Sympazan® (clobazam) oral film for the treatment of seizures associated with Lennox-Gastaut Syndrome. Our licensees market their products in the U.S. and around the world. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven drug development and commercialization capabilities. Aquestive is advancing a late-stage proprietary product pipeline focused on treating diseases of the central nervous system, or CNS, and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Aquestive Therapeutics has 75 employees across 12 departments.
Departments
Number of employees
Funding Data
Explore Aquestive Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Aquestive Therapeutics Tech Stack
Discover the technologies and tools that power Aquestive Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Form builders
Caching
Marketing automation
SEO
JavaScript libraries
Webmail
Miscellaneous
Programming languages
Blogs
Analytics
Font scripts
Netherlands
United Kingdom
Czechia
Frequently asked questions
4.8
40,000 users
